Drug standards to be used for screening and ation of suspected drug use in service member and/or post-mortem urine, blood and tissue samples.
Ended Awarded
- Contract number
- HT009025FG0810031
- Awardee
-
Cerilliant Corporation UEI JDDKSJ34EBZ7
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $37,500
Award facts
- Contract value 100% obligated
- $37,499.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325199 All Other Basic Organic Chemical Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Round Rock, TX 78665, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded Cerilliant Corporation a $37,499.78 firm fixed-price Blanket Purchase Agreement (BPA) call on August 8, 2025, for drug standards to be used in screening and confirmation testing of suspected drug use in service member urine, blood, and tissue samples, both for living personnel and post-mortem analysis. The contract represents a task order against Cerilliant's existing BPA with the Defense Health Agency and carries an ultimate completion date of September 30, 2025. The work will be performed in Round Rock, Texas, where Cerilliant maintains its headquarters as a global leader in certified reference materials and chemical and biological standards.
Cerilliant Corporation, a foreign-owned manufacturer specializing in high-quality reference standards and laboratory supplies, was awarded this contract without a set-aside designation, reflecting the company's specialized capabilities in forensic toxicology and drug testing materials. The vendor maintains several significant indefinite delivery vehicles with the Defense Health Agency and other federal agencies, including a $250,000 BPA for drug reference standards and laboratory supplies through September 2028. This contract supports the Defense Health Agency's mission to provide critical laboratory materials for military personnel drug screening and testing programs.
Quick answers
Who was awarded contract HT009025FG0810031?
HT009025FG0810031 was awarded to Cerilliant Corporation by Defense Health Agency (Department of Defense) on August 8, 2025.
How much is contract HT009025FG0810031 worth?
The government has obligated $37,500 on HT009025FG0810031.
Is contract HT009025FG0810031 an order under another contract?
Yes. HT009025FG0810031 is a BPA call under HT942523A0001, a blanket purchase agreement.
Was contract HT009025FG0810031 competed?
The extent of competition for HT009025FG0810031 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award